Premium
Late relapses in Hodgkin lymphoma – should we search for the needle in the haystack?
Author(s) -
ElGalaly Tarec Christoffer,
Glimelius Ingrid
Publication year - 2022
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.18199
Subject(s) - lymphoma , medicine , haystack , oncology , danish , population , hodgkin lymphoma , pediatrics , linguistics , philosophy , environmental health , world wide web , computer science
Hodgkin lymphoma is among the most curable cancers. For patients in remission for 24 months, residual lifetime becomes close to that of the background population. However, late relapses can occur after several years and, as shown by Andersen et al., the outcomes are not always good. Commentary on: Andersen MD, Hamilton‐Dutoit S, Modvig L, Vase M, Christiansen I, Christensen JH, et al. Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma – A study from the Danish Lymphoma Registry. Br J Haematol 2022;198:50‐61.